Cargando…
Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
BACKGROUND: This study was designed to establish a biomarker risk model for predicting bone metastasis in stage III non-small cell lung cancer (NSCLC). METHODS: The model consists of 105 cases of stage III NSCLC, who were treated and followed up. The patients were divided into bone metastasis group...
Autores principales: | Zhou, Zhen, Chen, Zhi-Wei, Yang, Xiao-Hua, Shen, Lan, Ai, Xing-Hao, Lu, Shun, Luo, Qing-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447731/ https://www.ncbi.nlm.nih.gov/pubmed/22537906 http://dx.doi.org/10.1186/1756-9966-31-34 |
Ejemplares similares
-
An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023) -
Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
por: Jin, Shi, et al.
Publicado: (2018) -
Emerging and Established Models of Bone Metastasis
por: Jinnah, Alexander H., et al.
Publicado: (2018) -
Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
por: Guo, Shan xian, et al.
Publicado: (2016) -
Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer
por: Xi, Yuhui, et al.
Publicado: (2017)